In the past decades, our knowledge about the relationship between cancer and the immune
system has increased considerably. Recent years' success of cancer immunotherapy …

Cancer is a leading cause of mortality worldwide, accounting for one in seven deaths
globally. 1–3 Progress has been made in treating cancer, but a significant proportion of …

Recent advances in cancer immunology have enabled the discovery of promising
immunotherapies for various malignancies that have shifted the cancer treatment paradigm …

Introduction: Cancer immunotherapy has evolved and is aimed at generating the efficacious
therapeutic modality to enhance the specificity and power of the immune system to combat …

The immune system interacts with cancer cells in multiple intricate ways that can shield the
host against hyper-proliferation but can also contribute to malignancy. Understanding the …

The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor
T cell therapies represent a turning point in cancer immunotherapy. These successes also …

With the huge therapeutic potential, cancer immunotherapy is expected to become the
mainstream of cancer treatment. In the current field of cancer immunotherapy, there are …

For many years, immunotherapeutic approaches for cancer held more promise than actual
clinical benefit for the majority of patients. However, several recent key advances in tumor …

Cancer immunotherapy uses the immune system and its components to mount an anti-tumor
response. During the last decade, it has evolved from a promising therapy option to a robust …

Cancer immunotherapy is demonstrating impressive clinical benefit in different malignancies
and clinical oncologists are increasingly turning their attention to immune-oncology. It is now …